⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCTX News
Briacell Therapeutics Corp. Common Shares
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
globenewswire.com
BCTX
Global Exosomes Market to Reach USD 2,250 Million by 2034 at 28.8% CAGR as Expanding Applications in Drug Delivery, Diagnostics, and Regenerative Medicine Fuel Market Growth, Reports Maximize Market Research
prnewswire.com
TMO
DHR
QGEN
BCTX
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
globenewswire.com
BCTX
Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
globenewswire.com
NTHI
BCTX
ONCY
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
globenewswire.com
BCTX
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
globenewswire.com
BCTX
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
globenewswire.com
BCTX
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
globenewswire.com
BCTX